These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5985304)

  • 1. Identification of chloramphenicol metabolites and some factors affecting metabolic disposition.
    Glazko AJ
    Antimicrob Agents Chemother (Bethesda); 1966; 6():655-65. PubMed ID: 5985304
    [No Abstract]   [Full Text] [Related]  

  • 2. Special characteristics of absorption and excretion of chloramphenicol in premature and newborn infants.
    Nishimura T; Kotani Y
    Bull Osaka Med Sch; 1970 Oct; 16(2):169-81. PubMed ID: 5511545
    [No Abstract]   [Full Text] [Related]  

  • 3. [Specificity of absorption and excretion of chloramphenicol in premature and newborn infants].
    Ura S
    Nihon Shonika Gakkai Zasshi; 1968 May; 72(5):697-705. PubMed ID: 5748795
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of chloramphenicol on the mother and baby. II. Transfer, absorption, excretion and adverse effects of chloramphenicol in the newborn infant].
    Kunii K
    Jpn J Antibiot; 1970 Aug; 23(4):363-78. PubMed ID: 5312787
    [No Abstract]   [Full Text] [Related]  

  • 5. Excretion of chloramphenicol and its metabolites by the chronically diseased kidney (with respect to the theory of adaptive nephrons).
    Schück O; Prát V; Grafnetterová J; Kotanová E; Reitschlägerová V; David I
    Int J Clin Pharmacol; 1974 Jul; 10(1):33-43. PubMed ID: 4851956
    [No Abstract]   [Full Text] [Related]  

  • 6. Absorption and excretion of two chloramphenicol products in humans after oral administration.
    Bartelloni PJ; Calia FM; Minchew BH; Beisel WR; Ley HL
    Am J Med Sci; 1969 Sep; 258(3):203-8. PubMed ID: 5824862
    [No Abstract]   [Full Text] [Related]  

  • 7. An evaluation of the absorption characteristics of different chloramphenicol preparations in normal human subjects.
    Glazko AJ; Kinkel AW; Alegnani WC; Holmes EL
    Clin Pharmacol Ther; 1968; 9(4):472-83. PubMed ID: 5655479
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative studies of chloramphenicol activity, fate and absorption in different suspensions.
    Galal EE; Raggal MH; Kamel HH; Sabbagh H; Mahmoud MA; Azzam AB
    J Egypt Med Assoc; 1965; 48():Suppl:89-97. PubMed ID: 5873680
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioavailability and clearance of chloramphenicol after intravenous chloramphenicol succinate.
    Nahata MC; Powell DA
    Clin Pharmacol Ther; 1981 Sep; 30(3):368-72. PubMed ID: 7273601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacologic study of chloramphenicol in cattle.
    Sisodia CS; Dunlop RH; Gupta VS; Taksas L
    Am J Vet Res; 1973 Sep; 34(9):1147-51. PubMed ID: 4747035
    [No Abstract]   [Full Text] [Related]  

  • 11. [The influence of pharmaceutical and physico-chemical factors of drugs on the result of clinical trials: chloramphenicol palmitate].
    van Oudtshoorn MC; Potgieter FJ; Koeleman HA; Pantonowitz LD
    S Afr Med J; 1969 Nov; 43(45):1375-6. PubMed ID: 4902056
    [No Abstract]   [Full Text] [Related]  

  • 12. Chloramphenicol metabolism in the phenobarbital-induced rat. Comparison with thiamphenicol.
    Bella DD; Marca G; Ferrari V; Bonanomi L
    Biochem Pharmacol; 1968 Dec; 17(12):2381-90. PubMed ID: 5720346
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum levels of chloramphenicol during simultaneous administration of penicillin in children].
    Windorfer A
    Z Kinderheilkd; 1972; 112(1):79-88. PubMed ID: 5019027
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of chronic administration of centrally acting compounds on chloramphenicol metabolism in schizophrenic patients.
    Watanabe A
    Pharmacology; 1974; 11(4):253-6. PubMed ID: 4156595
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of furosemide on the renal excretion of chloramphenicol and its metabolites.
    Schück O; Grafnetterová J; Prát V; Kotanová E
    Experientia; 1975 Dec; 31(12):1434-6. PubMed ID: 1213066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloramphenicol succinate kinetics in infants and young children.
    Sack CM; Koup JR; Opheim KE; Neeley N; Smith AL
    Pediatr Pharmacol (New York); 1982; 2(2):93-103. PubMed ID: 12760401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification and characterisation of chloramphenicol-aldehyde, a new human metabolite of chloramphenicol.
    Holt DE
    Eur J Drug Metab Pharmacokinet; 1995; 20(1):35-42. PubMed ID: 7588992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and metabolism of chloramphenicol in trout.
    Cravedi JP; Heuillet G; Peleran JC; Wal JM
    Xenobiotica; 1985 Feb; 15(2):115-21. PubMed ID: 4002733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of ethacrynic acid, hydrochlorothiazide and clopamide on the renal excretion of chloramphenicol and its metabolites.
    Schück O; Nádvorníková H; Grafnetterová J
    Int J Clin Pharmacol Biopharm; 1978 May; 16(5):217-9. PubMed ID: 649239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas chromatographic determination and gas chromatographic-mass sepectrometric analysis of chloramphenicol, thiamphenicol and their metabolites.
    Nakagawa T; Masada M; Uno T
    J Chromatogr; 1975 Sep; 111(2):355-64. PubMed ID: 1159013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.